Bcl-2-mediated/JJ
drug/NN
resistance/NN
:/:
inhibition/NN
of/IN
apoptosis/NN
by/IN
blocking/VBG
nuclear/JJ
factor/NN
of/IN
activated/VBN
T/NN
lymphocytes/NNS
(/(
NFAT/NN
)/)
-induced/JJ
Fas/NN
ligand/NN
transcription/NN
./.

Bcl-2/NN
inhibits/VBZ
apoptosis/NN
induced/VBN
by/IN
a/DT
variety/NN
of/IN
stimuli/NNS
,/,
including/VBG
chemotherapy/NN
drugs/NNS
and/CC
glucocorticoids/NNS
./.
=====
It/PRP
is/VBZ
generally/RB
accepted/VBN
that/IN
Bcl-2/NN
exerts/VBZ
its/PRP$
antiapoptotic/JJ
effects/NNS
mainly/RB
by/IN
dimerizing/VBG
with/IN
proapoptotic/JJ
members/NNS
of/IN
the/DT
Bcl-2/NN
family/NN
such/JJ
as/IN
Bax/NN
and/CC
Bad/NN
./.
=====
However/RB
,/,
the/DT
mechanism/NN
of/IN
the/DT
antiapoptotic/JJ
effects/NNS
is/VBZ
unclear/JJ
./.
=====
Paclitaxel/NN
and/CC
other/JJ
drugs/NNS
that/WDT
disturb/VBP
microtubule/NN
dynamics/NNS
kill/VBP
cells/NNS
in/IN
a/DT
Fas/Fas/NN
ligand/NN
(/(
FasL/NN
)/)
-dependent/JJ
manner/NN
;/:
antibody/NN
to/TO
FasL/NN
inhibits/VBZ
paclitaxel-induced/JJ
apoptosis/NN
./.
=====
We/PRP
have/VBP
found/VBN
that/IN
Bcl-2/NN
overexpression/NN
leads/VBZ
to/TO
the/DT
prevention/NN
of/IN
chemotherapy/NN
(/(
paclitaxel/NN
)/)
-induced/JJ
expression/NN
of/IN
FasL/NN
and/CC
blocks/VBZ
paclitaxel-induced/JJ
apoptosis/NN
./.
=====
The/DT
mechanism/NN
of/IN
this/DT
effect/NN
is/VBZ
that/IN
Bcl-2/NN
prevents/VBZ
the/DT
nuclear/JJ
translocation/NN
of/IN
NFAT/NN
(/(
nuclear/JJ
factor/NN
of/IN
activated/VBN
T/NN
lymphocytes/NNS
,/,
a/DT
transcription/NN
factor/NN
activated/VBN
by/IN
microtubule/JJ
damage/NN
)/)
by/IN
binding/VBG
and/CC
sequestering/VBG
calcineurin/NN
,/,
a/DT
calcium-dependent/JJ
phosphatase/NN
that/WDT
must/MD
dephosphorylate/VB
NFAT/NN
to/TO
move/VB
to/TO
the/DT
nucleus/NN
./.
=====
Without/IN
NFAT/NN
nuclear/JJ
translocation/NN
,/,
the/DT
FasL/NN
gene/NN
is/VBZ
not/RB
transcribed/VBN
./.
=====
Thus/RB
,/,
it/PRP
appears/VBZ
that/IN
paclitaxel/NN
and/CC
other/JJ
drugs/NNS
that/WDT
disturb/VBP
microtubule/JJ
function/NN
kill/VBP
cells/NNS
at/IN
least/JJS
in/IN
part/NN
through/IN
the/DT
induction/NN
of/IN
FasL/NN
./.
=====
Furthermore/RB
,/,
Bcl-2/NN
antagonizes/VBZ
drug-induced/JJ
apoptosis/NN
by/IN
inhibiting/VBG
calcineurin/NN
activation/NN
,/,
blocking/VBG
NFAT/NN
nuclear/JJ
translocation/NN
,/,
and/CC
preventing/VBG
FasL/NN
expression/NN
./.
=====
The/DT
effects/NNS
of/IN
Bcl-2/NN
can/MD
be/VB
overcome/VBN
,/,
at/IN
least/JJS
partially/RB
,/,
through/IN
phosphorylation/NN
of/IN
Bcl-2/NN
./.
=====
Phosphorylated/VBN
Bcl-2/NN
can/MD
not/RB
bind/VB
calcineurin/NN
,/,
and/CC
NFAT/NN
activation/NN
,/,
FasL/NN
expression/NN
,/,
and/CC
apoptosis/NN
can/MD
occur/VB
after/IN
Bcl-2/NN
phosphorylation/NN
./.